Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real-world evidence study.

Schwensen, J F B; Nielsen, V W; Nissen, C V; Sand, C; Gniadecki, R; Thomsen, S F

Schwensen, J F B; Nielsen, V W; Nissen, C V; Sand, C; Gniadecki, R; Thomsen, S F.

Schwensen JFB; Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
Nielsen VW; Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
Nissen CV; Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
Sand C; Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
Gniadecki R; Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen, Denmark.
Thomsen SF; Division of Dermatology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.

J Eur Acad Dermatol Venereol ; 35(5): e341-e343, 2021 May.

Article en En | MEDLINE | ID: mdl-33338282

Asunto(s)

Productos Biológicos; Psoriasis; Anticuerpos Monoclonales Humanizados; Humanos; Psoriasis/tratamiento farmacológico; Estudios Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Productos Biológicos Tipo de estudio: Observational_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google